Depression, fatigue, and functional disability in patients with chronic hepatitis C

Journal of Psychosomatic Research

Volumn 49, Issue 5, 2000, Pages 311-317

  Dwight, Megan M ^a,d   Kowdley, Kris V ^b   Russo, Joan E ^c   Ciechanowski, Paul S ^c   Larson, Anne M ^b   Katon, Wayne J ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic illness; Dysthymia; Fatigue; Hepatitis C; Major depression

Indexed keywords

ANTIDEPRESSANT AGENT; INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; FEMALE; FUNCTIONAL DISEASE; HEPATITIS C; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; RATING SCALE; RECURRENT DISEASE; SOMATIZATION;

ADOLESCENT; ADULT; AGED; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0034495841     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(00)00155-0     Document Type: Article

References (35)

1. The epidemiology of viral hepatitis in the United States
2. Long term clinical and histopathological follow-up of chronic post-transfusion hepatitis
3. Clinical outcomes after transfusion associated hepatitis C
4. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
5. Health assessment for chronic HCV infection: Results of quality of life
6. Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile
7. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
8. Fatigue assessment in patients with hepatitis C
9. Fatigue in patients with chronic hepatitis C
10. The impact of major depression on chronic medical illness
11. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease
12. Depression and the reporting of diabetes symptoms
13. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries
14. The functioning and well-being of depressed patients: Results from the medical outcomes study
15. Functional status in coronary artery disease: A one year prospective study of the role of anxiety and depression
16. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease
17. The NIMH diagnostic interview schedule
18. Agreement between face to face and telephone administered versions of the depression section of the NIMH diagnostic interview schedule
19. The NIMH diagnostic interview schedule modified to record current mental status
20. Comparison of self-reported fatigue in rheumatoid arthritis and controls
21. The MOS 36-item short form health survey (SF-36)
22. An inventory for measuring depression
23. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
24. The Duke severity of illness checklist for measurement of severity and comorbidity
25. Somatic symptoms and HIV infection: Relationship to depressive symptoms and indicators of HIV disease
26. Medically unexplained symptoms in primary care
27. Disability and depression among high utilizers of health care: A longitudinal analysis
28. Depression, anxiety, and social disability show synchrony of change in primary care patients
29. Outcome of depression and anxiety in primary care: A three wave 31/2 year study of psychopathology and disability
30. A randomized trial of nortriptyline for severe chronic tinnitus: Effects on depression, disability, and tinnitus symptoms
31. Do antidepressant work in depression in physical illness?
32. Interferons as mediators of psychiatric morbidity: An investigation in a trial of recombinant alpha interferon in hepatitis B carriers
33. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
34. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: Effect of baseline viral concentration. Consensus interferon study group